Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ceftobiprole medocaril (BAL5788) is the parenteral prodrug of Ceftobiprole. Ceftobiprole is a broad-spectrum cephalosporin with activity against Methicillin-resistant staphylococcus aureus (MRSA).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 45,000 | |||
5 mg | 在庫あり | ¥ 100,500 | |||
10 mg | 在庫あり | ¥ 148,500 | |||
25 mg | 在庫あり | ¥ 226,500 | |||
50 mg | 在庫あり | ¥ 317,000 |
説明 | Ceftobiprole medocaril (BAL5788) is the parenteral prodrug of Ceftobiprole. Ceftobiprole is a broad-spectrum cephalosporin with activity against Methicillin-resistant staphylococcus aureus (MRSA). |
In vivo | Ceftobiprole medocaril (10, 40, 160 mg/kg; single dose; sc) has T 1/2 s from 20 min to 31 min, as the dose rose from 40 mg/kg to 160 mg/kg. The AUC/dose values for the escalating single doses ranges from 0.585 to 1.33, and the C max /dose values decreases from 1.08 to 0.90 in neutropenic thigh-infected mice [1]. The drug showed activities in the lung model similar to those in the thigh model. |
別名 | BAL5788 |
分子量 | 690.66 |
分子式 | C26H26N8O11S2 |
CAS No. | 376653-43-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ceftobiprole medocaril 376653-43-9 Microbiology/Virology Antibacterial Inhibitor BAL 5788 penicillin cephalosporin inhibit gram-positive pyrrolidinone MRSA Bacterial BAL5788 vancomycin pathogens staphylococci BAL-5788 gram-negative VRSA methicillin Prodrug inhibitor